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Materials
All chemicals were purchased from Sigma Aldrich and used as received. Ultrapure water obtained from a Milli-Q direct water purification system was used to prepare all aqueous solutions. All spectroscopic measurements were carried out in DMSO:buffer (1:99) solutions. 1 and 2 were synthesized from the procedure reported in the literature. 1
Methods
1 H-NMR and 13 C-NMR were recorded on a ARX-400 Advance Bruker spectrometer. All chemical shifts (δ) are reported in ppm relative to DMSO-d 6 (2.50 ppm, 1 H; 39.52 ppm, 13 C) unless otherwise indicated. ESI-HRMS (high resolution mass spectrometry) were recorded at the PSU Bioanalytical Mass Spectrometry Facility on a ThermoElectron LTQ-Orbitrap high resolution mass spectrometer.
Spectrophotometric measurement
Fluorescence spectra were obtained on a Cary Eclipse fluorescence spectrophotometer (Agilent Technologies) with slit widths set at 5 nm for both excitation and emission, respectively. Fluorescence spectra were corrected for the wavelength dependent response of the R928 photomultiplier tube with the help of a manufacturer generated correction file.
pK a measurements
pKa values of the amine of 2-substituted thiazolidines/thiazinanes-4-carboxylic acids, 4a, 4b, 5a and 5b were obtained by the titration of their aqueous solutions with 0.01M NaOH. In the case of 3a and 3b 0.1 M NaOH was used. The pH measurements were conducted using an Orion 410A pH meter, which was standardized with Scientific Products potassium hydrogen phthalate pH 4.00 buffer, BDH pH 7.00 and Scientific Products boric acid/potassium hydroxide pH 10.00 buffer. All pH titrations were done in triplicates and their average is reported.
Deproteinization of plasma
Deproteinization of plasma was carried out by reconstituting the lyophilized bovine plasma with ultrapure water to 1/3 of the reconstitution volume. Two equivalents of acetonitrile (2/3 of the reconstitution volume) were added. This solution was vortexed for 10 min. after letting the solution stand for 10 minutes, it was centrifuged at 4000 RPM for 30 minutes to pellet the proteins. The decanted supernatant was aliquoted into sample vials and re-lyophilized. The vials were then sealed and stored in a refrigerator (4 ºC).
Synthesis of compounds 3a, 3b, 4a, 4b, 5a and 5b Scheme S1. Synthetic route of 3a, 4a and 5a L-cysteine (1.67 mmol) and salicylaldehyde (1.67 mmol) in 5 mL of distilled H 2 O are stirred at RT for 2 h. The precipitates are filtered, washed with iced cold H 2 O and dried under vacuum to yield 3a as a white solid (307 mg, 83% 88, 172.40, 155.13, 154.54, 128.99, 128.06, 127.85, 127.56, 126.04, 124.17, 118.99, 118.70, 116.62, 115.03, 67.61, 65.56, 65.13, 64.73, 38.10, 37. 
(2S,4R), (2S,4S), (2R,4R) and (2R,4S)-2-(2-hydroxyphenyl)-1,3-thiazinane-4-carboxylic acid (3b)
DL-homocysteine (1.88 mmol) and salicylaldehyde (1.88 mmol) in 6 mL of distilled water and 0.25 mL of ethanol are stirred at RT for two days. 
(2S,4S) and (2R,4S)-2-phenylthiazolidine-4-carboxylic acid (4a)
Compound 4a was prepared according to the procedure described for 3a but using benzaldehyde instead of salicylaldehyde. Compound 4a was obtained as white solid (488 mg 
(2S,4R), (2S,4S), (2R,4R) and (2R,4S)-2-phenyl-1,3-thiazinane-4-carboxylic acid (4b)
Compound 4b was prepared according to the procedure described for 3b but using benzaldehyde instead of salicylaldehyde in 6 mL of distilled H 2 O and stirred at RT for three days. Compound 4b was obtained as white solid (273 mg, 65% 
(S)-thiazolidine-4-carboxylic acid (5a)
Compound 5a was prepared according to the procedure described for 3a but using formaldehyde instead of salicylaldehyde. Figure S18 . Optical sensing behavior of 1 towards Cys and Hcy as compared to other biologically relevant species. Fluorescence response of 1 upon addition of different analytes (Cys, Hcy, GSH,Asn, Ala, Gln, Thr, Asp, Arg, His, Glu, 1 mM). All Solutions are composed of 4 µM of 1 with 1 mM analyte in phosphate buffer (100 mM, pH 6.0):DMSO 99:1 at 20 ºC, λ ex = 495nm λ em = 515 nm. 
